Corbenic Partners’s Intuitive Surgical ISRG Stock Holding History

Corbenic Partners’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15	Closed	-$5K	–	255
2021 Q4	$5K	Buy	+15	New	+$5.16K	﹤0.01%	212

Other funds holding ISRG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Corbenic Partners's ISRG Position: Q1 2022 in Review

Corbenic Partners sold out of Intuitive Surgical (ISRG) in Q1 2022, closing a stake of 15 shares — an estimated $5K sold.

Corbenic Partners first reported a position in ISRG in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 1,468 funds tracked by Wall St. Rank hold ISRG as of Q1 2022.

Corbenic Partners reported no remaining Intuitive Surgical position as of Q1 2022 after selling out during the quarter.
Corbenic Partners sold 15 Intuitive Surgical shares in Q1 2022, an estimated $5K.
Corbenic Partners first reported a position in Intuitive Surgical in Q4 2021 and held it in 1 quarter.
Corbenic Partners's Intuitive Surgical position peaked at $5K in Q4 2021.
1,468 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2022.

Based on Corbenic Partners's 13F filing for Q1 2022, filed 14 Apr 2022.